A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
The primary objective is to compare the safety and efficacy of multiple doses of ABT-494 versus placebo in moderately to severely active RA subjects on stable background MTX therapy with inadequate response or intolerance to anti-TNF biologic therapy.
Epistemonikos ID: 4fe7e2e3a653f1782c513af3a114d532521c795b
First added on: Mar 23, 2022